World's Best Scientists 2026 revealed!
Marcos González

Marcos González

D-Index & Metrics

Medicine

D-Index
90
Citations
34279
World Ranking
12104
National Ranking
169

Overview

Marcos González is affiliated with the University of Salamanca in Spain and is active in the field of Medicine, with a particular focus on Genetics, Pathology and Forensic Medicine, Molecular Biology, Immunology, and Oncology. Their work encompasses a variety of topics primarily related to hematologic malignancies and immune disorders.

The main topics of Marcos González's research include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Acute Myeloid Leukemia Research
  • Cancer Genomics and Diagnostics
  • Multiple Myeloma Research and Treatments
  • Glycosylation and Glycoproteins Research

Their recent publications demonstrate a consistent contribution to peer-reviewed journals in the hematology and oncology fields. Selected papers include:

  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia, 2022, Nature Medicine
  • Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma, 2020, Blood Cancer Journal
  • Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia, 2021, Blood
  • Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies, 2021, Blood Advances
  • Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC), 2020, British Journal of Haematology

Marcos González frequently collaborates with a number of researchers, indicating an active engagement in joint research efforts. Frequent co-authors include:

  • Miguel Alcoceba
  • Carmen Chillón
  • Ramón García-Sánz
  • María García-Álvarez
  • Alejandro Medina

The scientist's work appears consistently in several key publication venues, reflecting areas of specialization and research focus. The most frequent publication venues are:

  • Blood
  • Cancers
  • British Journal of Haematology
  • Blood Advances
  • Blood Cancer Journal

Best Publications

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    J Gabert;E Beillard;V H J van der Velden;W Bi

  • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde

  • Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

    Víctor Quesada;Laura Conde;Neus Villamor;Gonzalo R Ordóñez

  • Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Silvia Beà;Rafael Valdés-Mas;Neus Villamor

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    J Flores-Montero;L Sanoja-Flores;B Paiva;N Puig

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

    Miguel A. Sanz;Guillermo Martín;Marcos González;Angel León

  • A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

    Miguel A. Sanz;Guillermo Martı́n;Consuelo Rayón;Jordi Esteve

  • Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study

    Bruce M Biccard;Thandinkosi E Madiba;Hyla-Louise Kluyts;Dolly M Munlemvo

  • Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.

    Pongers-Willemse Mj;Seriu T;Stolz F;d'Aniello E

  • Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

    Joaquin Martinez-Lopez;Juan J. Lahuerta;François Pepin;Marcos González

  • Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.

    Jesús F. San Miguel;Marı́a B. Vidriales;Consuelo López-Berges;Joaquı́n Dı́az-Mediavilla

  • Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics

    R. Garcı́a-Sanz;A. Orfão;M. González;M.D. Tabernero

  • Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

    Javier de Serna;Pau Montesinos;Edo Vellenga;Chelo Rayón

  • Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

    Pau Montesinos;Juan M. Bergua;Edo Vellenga;Chelo Rayón

  • Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

    A. López-Guillermo;J. Cid;A. Salar;A. López

  • Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia

    Ferran Nadeu;Julio Delgado;Cristina Royo;Tycho Baumann

  • Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

    Sı́lvia Beà;Maria Ribas;Jesús M. Hernández;Francesc Bosch

  • A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia

    C Cobaleda;N Gutiérrez-Cianca;J Pérez-Losada;T Flores

Frequent Co-Authors

Ramón García-Sanz
Ramón García-Sanz University of Salamanca
Jesús F. San Miguel
Jesús F. San Miguel University of Navarra
Alberto Orfao
Alberto Orfao University of Salamanca
Julia Almeida
Julia Almeida University of Salamanca
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Dolors Colomer
Dolors Colomer University of Barcelona
David Gonzalez
David Gonzalez University of California, San Diego
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Albert Oriol
Albert Oriol Autonomous University of Barcelona
Neus Villamor
Neus Villamor University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a variety of rewarding career options beyond the traditional MD route. Many healthcare professionals begin their journey with a Bachelor of Science in Nursing, and for those looking to maximize value, the cheapest bsn programs online can help students earn their degrees at a lower cost.

Registered Nurses (RNs) seeking to advance their qualifications can benefit from the cheapest rn to bsn online programs, designed as flexible pathways to earning a bachelor’s degree while continuing to work.

For those interested in advanced practice or leadership roles, entry-level master’s options are available—even for non-nursing graduates. The entry level msn programs online offer a direct route to a Master of Science in Nursing for career changers.

Nurses aiming for the top research, teaching, or executive positions can consider the cheapest phd nursing programs, which deliver rigorous doctoral training in a flexible online format.

These online pathways provide accessible and affordable opportunities for prospective health professionals to advance their careers in medicine or nursing.

Best Scientists Citing Marcos González

Trending Scientists